Think about the last time you searched for something specific—maybe a product comparison or a technical fix. Ideally, you ...
Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...
Teri List Former Executive Vice President and Chief Financial Officer, The Gap, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results